Researchers at KTH Royal Institute of Technology in Sweden conducted viral prophylactic tests on several types of cells using a lubricant that was derived from bovine mucin in purified form for fabrication of hydrogels (Advanced Science, September 14, 2022). Mucin molecules are biologically complex so they are effective at stopping HIV and herpes without the risk of side effects or development of resistance as with other antiviral compounds, the researchers said.

Mucin molecules bind to and trap virus particles, which are then cleared through active mucus turnover. The synthetic gel replicates this process and is the key material property that enables mucus' lubricity and prophylaxis against infection. Also, mucins dampen immune cell activation, which is important because activated immune cells can stimulate HIV replication.

The gel could help more people take greater control of their sexual health by offering protection when a condom is not an available option, or as a backup in case of condom failure or incorrect use, according to the researchers.

Study finds mucins evolved from nonmucin proteins
Scientists have discovered 15 instances in which new mucins appear to have evolved through an additive process that transformed a nonmucin protein into...

New in vitro models offer effective way to study respiratory viruses
A new accessible and scalable protocol for manufacturing in vitro lung cell models could have applications in the development of new therapies for respiratory...

Should more COVID-19 research be based on mucosal immunity?
As most COVID-19 tests are based on nasal swabs or saliva samples that measure the amount of SARS-CoV-2 virus in the mouth or nose, it is important to...